Jason's practice emphasizes securities regulations and public offerings. Jason counsels public companies on Securities Exchange Act of 1934, NYSE and NASDAQ compliance and disclosure issues. Jason has reviewed and drafted numerous 1933 and 1934 Act filings. Jason also advises public company clients regarding disclosure controls and procedures, Sarbanes-Oxley Act, executive compensation, corporate governance, corporate finance and Section 16 compliance. Jason's securities experience also includes representation of issuers and underwriters in public securities offerings, including initial public offerings. He has also worked on spin-offs, PIPEs, 144A offerings, shelf registrations, private placements and tender offers.
In addition, Jason represents buyers and sellers in public and private company mergers and acquisitions. He also represents emerging companies in venture capital financing transactions and general corporate matters.
Jason has represented clients ranging from large Fortune 500 companies to small private emerging businesses across a variety of industries.
Jason joined the firm in 2006 as an associate. He previously practiced in the Washington, DC office of a major international law firm.
Representative Transactions
Recent transactions include:
Securities Offerings
- Representation of Piper Jaffray in connection with the initial public offering of GenMark Diagnostics, Inc.
- Representation of tw telecom inc. in a $430 million debt offering and related debt tender offer
- Representation of Crocs, Inc. in its cash tender offer for stock options
- Representation of VeraSun Energy Corporation in connection with its $450 million Rule 144A debt offering and subsequent exchange offer
- Representation of Piper Jaffray in connection with an underwritten secondary offering of Sirenza Micro Devices common stock
- Representation of tw telecom inc. in connection with its $770 million secondary public offering
- Representation of Crocs, Inc. in connection with its $248 million secondary public offering
- Representation of DaVita Inc. in connection with its purchase of NxStage Medical, Inc. common stock in a PIPE transaction
- Representation of an NYSE listed technology company in connection with multiple primary and secondary public offerings exceeding $1.3 billion in the aggregate
- Representation of insurance, retail and medical device companies in connection with their initial public offerings
- Representation of various underwriters in connection with underwritten public offerings
- Representation of multiple issuers in connection with shelf registration statements
- Representation of numerous issuers and investors in connection with private placements of securities, including venture capital investments
Mergers and Acquisitions
- Representation of MX Logic in connection with its sale to McAfee
- Representation of Flextronics International Ltd. in connection with its acquisition of Avail Medical Products
- Representation of StorePerform Technologies, Inc. in connection with its sale to RedPrairie Corporation
- Representation of Crocs, Inc. in connection with the acquisitions of Jibbitz, LLC and Bite Footwear
- Representation of RF Micro Devices, Inc. in connection with its acquisition of Universal Microwave Corporation
- Representation of private equity funds in connection with their acquisitions of various public and private companies
- Representation of various financial institutions in acquisitions and divestitures